A report that pools data from 16 studies concludes that the FDA should have halted research years earlier because of increased incidence of heart attacks and deaths. ...
... miniature mechanical pump that helps weak hearts pump blood -- that has now received approval by the FDA as of April 21 for broad use as bridge to transplantation. As part of clinical trials leading ...
... to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline and Ligand Pharmaceuticals is effective for short-term use, despite reservations by FDA scientists....
The U.S. Food and Drug Administration (FDA) has approved the NeuRx Diaphragm Pacing System (DPS) for spinal cord-injured patients who are dependent on ventilators for breathing. The light-weight, ...
FDA warns consumers to avoid eating fresh jalapenos.
... with rare but serious side effects, and both were candidates for a "black box" warning, the strongest the FDA issues short of taking a drug off the market. Although one was hit with this safety ...
A chemical used in baby bottles, canned food and other items is not dangerous, FDA says.
... to kill E. coli, salmonella and listeria – microorganisms that make people sick. The FDA has approved the use of irradiation to eliminate insects from wheat, potatoes, flour, spices, tea, fruits and ...
... treatments, say the authors.
These new results provide a baseline for monitoring the effects of the FDA Amendments Act 2007, which was introduced to improve the accuracy and completeness of drug ...
WASHINGTON (AP) -- An independent panel of science advisers is taking issue with the FDA's assessment that a controversial chemical is safe....
... access journal PLoS Medicine. Among those trials published, unexplained discrepancies between the FDA submissions and their corresponding publications—the addition or deletion of outcomes, changes in ...
... professional meeting on epilepsy discussed multiple questions and concerns they have about data presented by the FDA in support of its recent suicide alert on anticonvulsant drugs (AEDs) and the ...
LSRO finds insufficient evidence to support a cardiovascular disease or diabetes health claim when considering only studies that conform to the FDA definition of whole grains.
Among the doctors' concerns is that news reports of the FDA's analyses have confused patients and, perhaps, some physicians on the risks associated with epilepsy drugs. They cite data showing that the ...
... a move signaling the beginning of a new age in stem cell research, the Food and Drug Administration (FDA) has approved the first-ever clinical trial of stem cell therapy on human subjects. The trial, ...
